Cornelis Alexander Izeboud
Director/Board Member at TME PHARMA N.V.
Cornelis Alexander Izeboud active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TME PHARMA N.V. | Director/Board Member | 2020-06-29 | - |
| Independent Dir/Board Member | 2020-06-29 | - | |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
NOMAD Bioscience GmbH
 NOMAD Bioscience GmbH BiotechnologyHealth Technology NOMAD Bioscience GmbH provides research and development services in the field of biomaterials. It holds interests in the biotechnologies, biogas, biofuel, and medicinal products. The company was founded by Yuri Gleba in 2008 and is headquartered in Munich, Germany. | Director/Board Member | 2020-03-31 | - |
Career history of Cornelis Alexander Izeboud
Former positions of Cornelis Alexander Izeboud
| Companies | Position | Start | End |
|---|---|---|---|
| NIBC Bank NV (Research Firm) | Analyst-Equity | - | 2020-06-30 |
Luciole Medical AG
 Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Director/Board Member | 2019-05-13 | - |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Analyst-Equity | - | - |
Training of Cornelis Alexander Izeboud
| University of Utrecht | Doctorate Degree |
Statistics
International
| Netherlands | 5 |
| Germany | 3 |
| Switzerland | 2 |
Operational
| Director/Board Member | 4 |
| Analyst-Equity | 2 |
| Doctorate Degree | 1 |
Sectoral
| Finance | 3 |
| Health Technology | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TME PHARMA N.V. | Health Technology |
| Private companies | 5 |
|---|---|
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Finance |
| NIBC Bank NV (Research Firm) | Finance |
Luciole Medical AG
Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Technology Services |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Commercial Services |
NOMAD Bioscience GmbH
NOMAD Bioscience GmbH BiotechnologyHealth Technology NOMAD Bioscience GmbH provides research and development services in the field of biomaterials. It holds interests in the biotechnologies, biogas, biofuel, and medicinal products. The company was founded by Yuri Gleba in 2008 and is headquartered in Munich, Germany. | Health Technology |